Literature DB >> 28917841

Graphene-VP40 interactions and potential disruption of the Ebola virus matrix filaments.

Jeevan B Gc1, Rudramani Pokhrel1, Nisha Bhattarai1, Kristen A Johnson2, Bernard S Gerstman3, Robert V Stahelin4, Prem P Chapagain5.   

Abstract

Ebola virus infections cause hemorrhagic fever that often results in very high fatality rates. In addition to exploring vaccines, development of drugs is also essential for treating the disease and preventing the spread of the infection. The Ebola virus matrix protein VP40 exists in various conformational and oligomeric forms and is a potential pharmacological target for disrupting the virus life-cycle. Here we explored graphene-VP40 interactions using molecular dynamics simulations and graphene pelleting assays. We found that graphene sheets associate strongly with VP40 at various interfaces. We also found that the graphene is able to disrupt the C-terminal domain (CTD-CTD) interface of VP40 hexamers. This VP40 hexamer-hexamer interface is crucial in forming the Ebola viral matrix and disruption of this interface may provide a method to use graphene or similar nanoparticle based solutions as a disinfectant that can significantly reduce the spread of the disease and prevent an Ebola epidemic.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ebola virus; Graphene sheet; Matrix filaments; Nanotherapy; VP40

Mesh:

Substances:

Year:  2017        PMID: 28917841      PMCID: PMC5636687          DOI: 10.1016/j.bbrc.2017.09.052

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  38 in total

Review 1.  Empirical force fields for biological macromolecules: overview and issues.

Authors:  Alexander D Mackerell
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

2.  Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography.

Authors:  Tanmay A M Bharat; Takeshi Noda; James D Riches; Verena Kraehling; Larissa Kolesnikova; Stephan Becker; Yoshihiro Kawaoka; John A G Briggs
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

3.  Effect of graphene oxide on the conformational transitions of amyloid beta peptide: A molecular dynamics simulation study.

Authors:  Lokesh Baweja; Kanagasabai Balamurugan; Venkatesan Subramanian; Alok Dhawan
Journal:  J Mol Graph Model       Date:  2015-07-28       Impact factor: 2.518

Review 4.  Structural disorder throws new light on moonlighting.

Authors:  Peter Tompa; Csilla Szász; László Buday
Journal:  Trends Biochem Sci       Date:  2005-09       Impact factor: 13.807

5.  Evaluating Ebola therapies--the case for RCTs.

Authors:  Edward Cox; Luciana Borio; Robert Temple
Journal:  N Engl J Med       Date:  2014-12-03       Impact factor: 91.245

6.  Potential disruption of protein-protein interactions by graphene oxide.

Authors:  Mei Feng; Hongsuk Kang; Zaixing Yang; Binquan Luan; Ruhong Zhou
Journal:  J Chem Phys       Date:  2016-06-14       Impact factor: 3.488

7.  The multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target.

Authors:  Jonathan J Madara; Ziying Han; Gordon Ruthel; Bruce D Freedman; Ronald N Harty
Journal:  Future Virol       Date:  2015-05       Impact factor: 1.831

8.  Molecular Dynamics of Fibrinogen Adsorption onto Graphene, but Not onto Poly(ethylene glycol) Surface, Increases Exposure of Recognition Sites That Trigger Immune Response.

Authors:  Nadiya Dragneva; Oleg Rubel; Wely B Floriano
Journal:  J Chem Inf Model       Date:  2016-03-23       Impact factor: 4.956

9.  Rebuilding transformation strategies in post-Ebola epidemics in Africa.

Authors:  Ernest Tambo; Chryseis F Chengho; Chidiebere E Ugwu; Isatta Wurie; Jeannetta K Jonhson; Jeanne Y Ngogang
Journal:  Infect Dis Poverty       Date:  2017-05-10       Impact factor: 4.520

Review 10.  Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule.

Authors:  Nancy J Sullivan; Julie E Martin; Barney S Graham; Gary J Nabel
Journal:  Nat Rev Microbiol       Date:  2009-05       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.